Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Herriot Tabuteau0
Date of Patent
April 16, 2024
0Patent Application Number
178486850
Date Filed
June 24, 2022
0Patent Citations
Patent Primary Examiner
Patent abstract
Described herein are methods for the administration of reboxetine, or a pharmaceutically acceptable salt thereof, to a human being in need thereof, resulting in a first maximum plasma concentration and a second maximum plasma concentration, wherein the two maxima are separated by a time period of about 2 hours to about 6 hours.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
